California APRN Course Bundle

Course Overview

Course Authors

• Janice Tazbir RN, CS, CCRN, CNE, RYT
• Edith Fomuso MSN, CCM, RN
• Jillian Hay-Roe RNC-NIC
• Amy White CNO, PRN
• Maureen Sullivan MS, BSN, RN, CEN, CDE
• Sarah Schulze MSN, NP
• Michael York MSN, RN
• Esther Van Baren MSN, RN
• Joanne Kuplicki BSN, RN
• Marian Oliver BSN, RNC, CMC, PMH-BC
• Morgan Curry BSN, RN
• Atana Collins MSN, RN, CDN
• Daphne Day RN, SANE-A
• Molina Allen RN
• Lauren Stephanoff BSN, RN

Course Outline

Part 1 Includes

1. Schedule II Controlled Substances and the Risks of Addiction
2. Schedule II Controlled Substances and Neonatal Abstinence Syndrome
3. Safe Prescribing of Opioid Drugs
4. Tirzepatide for Type 2 Diabetes and Weight Management
5. Semaglutide and Type 2 Diabetes
6. Medication Assisted Treatment
7. Following a DNR: An Ethical Dilemma in Nursing
8. Managing Conflict in a Nurse Leader Role

Part 2 Includes

1. A-fib and Stroke Risk
2. Ethics for the Telehealth Nurse
3. One Hour Sepsis Bundle
4. Renal Failure Stages, Treatment and Outcomes
5. Screening for Suicide Risk Factors in Pediatrics
6. Human Trafficking
7. Pain Management in Nursing
8. A Nurse’s Guide: How to Deal with Difficult Patients

Accreditation Statement

Nursing CE Central is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

This course will require the average learner 1,500 minutes to complete and awards 30 contact hours of nursing continuing education, including 12 pharmacological contact hours.

Course Objectives

After completing this course, the learner will rate 4 out of 5 on the Likert Scale for their ability to:

1. Incorporate pharmacokinetic and pharmacodynamic principles of Schedule II medications to safely prescribe medications in the part of care for patients experiencing pain.
2. Demonstrate an understanding of the pharmacokinetics and pharmacodynamics related to Schedule II controlled substances in relationship to women’s health and neonatal care. 
3. Describe factors when prescribing opioids, their indications, and their effects.
4. Analyze the indications of usage for tirzepatide in diabetes and weight loss management.   
5. Discuss the long-term use of semaglutide injectables specific to the treatment of type 2 diabetes.
6. Understand a nurse’s role in caring for patients receiving medication-assisted treatment.
7. Explain what a DNR is and what it is not.
8. Understand the risk assessment process for stroke in A-Fib. 

Target Audience

• Registered Nurses (RN)
• Advanced Practice Registered Nurses (APRN)
• Licensed Practical Nurses (LPN/LVN)

Requirement for Completion

1. Enrollment in the course by the learner
2. Read and learn all course materials
3. Complete the course evaluation
4. Attest and testify learning of the course materials

Accreditations + Approvals

Conflict of Interest Statement